Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Lupus Therapeutics collaborates with Takeda on phase I trial of TAK-079 for SLE

March 4, 2019

Bristol-Myers Squibb presents lysophospholipid S1P1 receptor agonists

March 4, 2019

Azetidine optimization leads to clinical candidate JTE-952 for rheumatoid arthritis

March 1, 2019

Miransertib shows promising therapeutic efficacy in children with Proteus syndrome

Feb. 28, 2019

Nodthera patents NLRP3 inflammasome inhibitors

Feb. 28, 2019

Toll-like receptor 7/8/9 antagonists discovered at Bristol-Myers Squibb

Feb. 26, 2019

Bristol-Myers Squibb identifies TLR7/8/9 antagonists

Feb. 22, 2019

EZH2 inhibitors may be a means of treating scleroderma

Feb. 20, 2019

Topline results from Japanese confirmatory phase III study of ONO-5704 in knee osteoarthritis

Feb. 19, 2019

FASST study of lanifibranor in diffuse cutaneous systemic sclerosis does not meet primary endpoint

Feb. 19, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....